Search results
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
Motley Fool via Yahoo Finance· 3 days agoAstraZeneca (NASDAQ: AZN) is embarking on a fresh business plan that will see it grow significantly...
This Pharma Stock Is Poised to Keep Outperforming the S&P 500 | The Motley Fool
The Motley Fool· 2 days agoAstraZeneca (AZN 1.23%), recognized as the world's sixth-largest pharmaceutical entity by market...
AstraZeneca stock upgraded by Goldman, 27% upside seen By Investing.com
Investing.com· 2 days agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN)...
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock? | The Motley Fool
The Motley Fool· 3 days agoAstraZeneca (AZN -0.70%) is embarking on a fresh business plan that will see it grow significantly...
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC NEWS· 17 hours agoStarting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price...
AstraZeneca shares target raised by Argus on new drug approvals By Investing.com
Investing.com· 2 days agoOn Thursday, AstraZeneca PLC (NASDAQ:LON:AZN) shares received an updated price target from a market...
New antibiotic based on AstraZeneca drugs kills off deadly bacteria, spares the good guys
FierceBiotech· 1 day agoA new antibiotic based on drugs developed by AstraZeneca can kill off dangerous bacteria that cause...
Cramer's Lighting Round: ‘You've got a winner' with Astra Zeneca
NBC Los Angeles· 18 hours ago“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to...
AstraZeneca PLC (NASDAQ:AZN) Stock Holdings Lifted by Hsbc Holdings PLC
ETF DAILY NEWS· 2 days agoHsbc Holdings PLC raised its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 13.7% during the fourth quarter, according to its most recent Form 13F filing with the ...
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters via AOL· 4 days agoAmgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex...